Many Marylanders struggle with obesity but cannot get access to weight loss medications because insurance will not pay for ...

AbbVie will pay up to $2.2 billion to develop Danish drugmaker Gubra's obesity drug. AI takes center stage at HIMSS ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

Over half of all adults — and a third of children and young adults — around the world are expected to be overweight or obese ...

A leading A&E doctor has warned about the dangers of weight loss jabs after an investigation found a major high street ...

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...

Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range ...

The Food and Drug Administration on Friday said the shortage of Novo Nordisk's weight-loss and diabetes drugs Wegovy and Ozempic is resolved, a move that could limit the availability of cheaper ...

The "Hims and Hers" commercial railed against the weight loss industry and promoted the company's weight loss drug offerings as a less costly option compared to brand-name drugs. ABC News chief ...

WESH 2's Jason Guy and Orlando Health Weight Loss & Bariatric Surgery Institute surgeon, Dr. Muhammad Ghanem, discuss potential influences on the downward trend ...

The Maine Legislature is considering a bill that would require MaineCare to cover popular weight loss drugs like Ozempic. The ...

The "Hims and Hers" commercial railed against the weight loss industry and promoted the company's weight loss drug offerings as a less costly option compared to brand-name drugs. ABC News chief ...